Terumo Acquires Sequent Medical, U.S.-based Developer of New Aneurysm Embolization Device
FDA Lifts All Remaining Shipping Restrictions at Terumo Cardiovascular Systems' Ann Arbor Facility
Terumo Launches HeartSheet®: A Global First Cellular and Tissue-based Product Designed for the Treatment of Heart Failure
Notice of Convocation of the 101st Annual General Meeting of Shareholders
Financial Results for Fiscal Year Ended 3/2016
Copyright (C) TERUMO CORPORATION, All Rights Reserved.
Return to page top